First Anticoagulant Approved to Treat Symptomatic VTE in Pediatric Patients - Pulmonology Advisor

First Anticoagulant Approved to Treat Symptomatic VTE in Pediatric Patients  Pulmonology Advisor

The FDA has approved Fragmin, a low molecular weight heparin, for the treatment of symptomatic venous thromboembolism to reduce the recurrence of VTE in ...